| Diane Buckley, MD | |
|
800 Rose St, Lexington, KY 40536-7001 | |
| (859) 562-1085 | |
| (859) 257-5152 |
| Full Name | Diane Buckley |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 800 Rose St, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013448505 | NPI | - | NPPES |
| Entity Name | University Of Kentucky |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770771974 PECOS PAC ID: 3072425289 Enrollment ID: O20031105000072 |
News Archive
Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD).
According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
The COVID-19 pandemic has created an urgent need for sharing patient data to help scientists learn more about the virus and how to stop it from spreading.
Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.
A study published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, held April 2-6, showed how evaluating the immune response in the tumor microenvironment may help researchers better target therapy in breast cancer.
› Verified 2 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD).
According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
The COVID-19 pandemic has created an urgent need for sharing patient data to help scientists learn more about the virus and how to stop it from spreading.
Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.
A study published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, held April 2-6, showed how evaluating the immune response in the tumor microenvironment may help researchers better target therapy in breast cancer.
› Verified 2 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD).
According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
The COVID-19 pandemic has created an urgent need for sharing patient data to help scientists learn more about the virus and how to stop it from spreading.
Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.
A study published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, held April 2-6, showed how evaluating the immune response in the tumor microenvironment may help researchers better target therapy in breast cancer.
› Verified 2 days ago
| Entity Name | Norton Childrens Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326695255 PECOS PAC ID: 3779917596 Enrollment ID: O20200102000758 |
News Archive
Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD).
According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
The COVID-19 pandemic has created an urgent need for sharing patient data to help scientists learn more about the virus and how to stop it from spreading.
Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.
A study published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, held April 2-6, showed how evaluating the immune response in the tumor microenvironment may help researchers better target therapy in breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diane Buckley, MD Po Box 776879, Chicago, IL 60677-6879 Ph: () - | Diane Buckley, MD 800 Rose St, Lexington, KY 40536-7001 Ph: (859) 562-1085 |
News Archive
Researchers at the University of California, San Diego School of Medicine have identified a gene variant that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD).
According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
The COVID-19 pandemic has created an urgent need for sharing patient data to help scientists learn more about the virus and how to stop it from spreading.
Magnetic resonance images (MRI) of a large group of patients with multiple sclerosis has provided the first evidence that those with a history of MS in their families show more severe brain damage than patients who have no close relatives with the disease.
A study published in Cancer Discovery, the newest journal of the American Association for Cancer Research, debuting here at the AACR 102nd Annual Meeting 2011, held April 2-6, showed how evaluating the immune response in the tumor microenvironment may help researchers better target therapy in breast cancer.
› Verified 2 days ago
Preeti Ramachandran, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St Fl Ha4, Lexington, KY 40536 Phone: 859-323-6754 Fax: 859-323-6754 | |
Robin L Feese, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1780 Nicholasville Rd, Ste 301, Lexington, KY 40503 Phone: 859-277-6636 Fax: 859-277-1455 | |
Dr. Mina Hazem Halim Hanna, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 800 Rose St # Ms 471, Lexington, KY 40536 Phone: 248-854-3120 Fax: 859-323-8031 | |
Jacob A Bishop, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 245 Fountain Ct, Lexington, KY 40509 Phone: 859-323-6861 | |
Donna Glandon Grigsby, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5481 | |
Dr. John Charles Vance, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1760 Nicholasville Rd, Suite 406, Lexington, KY 40503 Phone: 859-276-1221 Fax: 859-278-0047 | |
Dr. Kimberly Renee Dennis Northrip, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 740 S Limestone, J426, Lexington, KY 40536 Phone: 859-323-6426 |